JACKSONVILLE -- A U.S. District Court judge in Delaware is expected to decide in the next few weeks whether Ranbaxy Pharmaceuticals Inc.'s generic version of Pfizer Inc.'s Lipitor should be allowed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback